Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
) for engineering systems. Our research covers surrogate modeling, reliability analysis, sensitivity analysis, optimization under uncertainty, and Bayesian calibration. We are known for developing the UQLab software
-
the admission requirements for a PhD at ETH Zurich Experience in machine learning, optimization, or AI-driven decision-making Preferably with knowledge of Bayesian optimization or Gaussian processes
-
) for engineering systems. Our research covers surrogate modeling, reliability analysis, sensitivity analysis, optimization under uncertainty, and Bayesian calibration. We are known for developing the UQLab software
-
recovery trajectories and injury patterns. Integrate personalized physiological measurements into a recovery prediction model, while adapting Bayesian Neural Networks for SCI data and analyzing the impact on
-
: Experience in machine learning, optimization, or AI-driven decision-making Preferably knowledge of Bayesian optimization or Gaussian processes Programming experience (Python, MATLAB, or similar) Soft Skills
-
), Multi-armed Bandits, Bayesian Optimization. Automated Model Design and Tuning: Neural Architecture Search, Hyperparameter Optimization. Computer Networking: Resource-Constrained Networking (e.g., Internet
-
and innovative POM research with high relevance. We publish across engineering and management disciplines, targeting top conferences and journals. Emphasis is on top empirical research in collaboration
-
) or neural network-based methods. The level of the targeted problems will require further mathematical and algorithmic developments over the current state of data-driven SSM reduction. The PhD position will
-
, functional genomics, protein engineering, and targeted protein degradation. Project background High-throughput perturbation technologies rely on perturbing DNA or RNA to infer the function of proteins. Methods
-
to establish an innovative platform for peptide drug discovery. Project background Peptides are privileged modalities for the development of new therapeutic avenues. To address unexploited targets and offer